BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37198549)

  • 1. Sucrosomial® iron effectiveness in recovering from mild and moderate iron-deficiency anemia in the postpartum period.
    Antoine E; Mehedintu C; Mitran M; Diculescu D
    BMC Pregnancy Childbirth; 2023 May; 23(1):360. PubMed ID: 37198549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.
    Mafodda A; Giuffrida D; Prestifilippo A; Azzarello D; Giannicola R; Mare M; Maisano R
    Support Care Cancer; 2017 Sep; 25(9):2779-2786. PubMed ID: 28391437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of pre-operative oral Sucrosomial® iron supplementation in cardiac surgery: influence of patient's baseline hemoglobin and gender.
    Weltert LP; De Rosa A; Rondinelli MB; Falco M; Turani F; Pierelli L
    Blood Transfus; 2023 Jul; 21(4):305-313. PubMed ID: 36580029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR
    Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia.
    Abbati G; Incerti F; Boarini C; Pileri F; Bocchi D; Ventura P; Buzzetti E; Pietrangelo A
    Intern Emerg Med; 2019 Apr; 14(3):423-431. PubMed ID: 30499070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between non-anemic iron deficiency in early pregnancy and perinatal mental health: A retrospective pilot study.
    Ohsuga T; Egawa M; Kii M; Ikeda Y; Ueda A; Chigusa Y; Mogami H; Mandai M
    J Obstet Gynaecol Res; 2022 Nov; 48(11):2730-2737. PubMed ID: 36054581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA.
    Zuccarini A; Cicognini D; Tancredi R; Ferrari A; Rizzo G; Lasagna A; Caccialanza R; Cavanna L; Orlandi E; Biasini C; Molinaro P; Garigliano D; Costantino A; Moroni M; Perrone L; Alessio NL; Rovati B; Ferretti VV; Klersy C; Pedrazzoli P
    Support Care Cancer; 2022 Sep; 30(9):7645-7653. PubMed ID: 35678882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment.
    Bastida G; Herrera-de Guise C; Algaba A; Ber Nieto Y; Soares JM; Robles V; Bermejo F; Sáez-González E; Gomollón F; Nos P
    Nutrients; 2021 May; 13(6):. PubMed ID: 34067320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).
    Reinisch W; Staun M; Tandon RK; Altorjay I; Thillainayagam AV; Gratzer C; Nijhawan S; Thomsen LL
    Am J Gastroenterol; 2013 Dec; 108(12):1877-88. PubMed ID: 24145678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucrosomial Iron Supplementation in Anemic Patients with Celiac Disease Not Tolerating Oral Ferrous Sulfate: A Prospective Study.
    Elli L; Ferretti F; Branchi F; Tomba C; Lombardo V; Scricciolo A; Doneda L; Roncoroni L
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29522446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study to Gain First Indications for the Impact of a 3-Month's Oral Intake of a Sucrosomial Iron Supplement on Hemoglobin in Iron-Deficient Blood Donors.
    Torreiter PP; Drexler-Helmberg C; Schimetta W; Krakowitzky P; Helmberg W; Schlenke P
    Transfus Med Hemother; 2023 Aug; 50(4):286-293. PubMed ID: 37767276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An added value for the hemoglobin content in reticulocytes (CHr) and the mean corpuscular volume (MCV) in the diagnosis of iron deficiency in postpartum anemic women.
    Ramakers C; van der Woude DA; Verzijl JM; Pijnenborg JM; van Wijk EM
    Int J Lab Hematol; 2012 Oct; 34(5):510-6. PubMed ID: 22548729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of postpartum anaemia and iron deficiency by serum ferritin, soluble transferrin receptor and total body iron, and associations with ethnicity and clinical factors: a Norwegian population-based cohort study.
    Næss-Andresen ML; Jenum AK; Berg JP; Falk RS; Sletner L
    J Nutr Sci; 2022; 11():e46. PubMed ID: 35754987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron supplementation in pregnant Danish women revisited: Effects on prepartum and postpartum iron deficiency, anemia, serum erythropoietin; including iron status, erythropoietin and anthropometrics in newborns. A randomized, placebo-controlled study.
    Milman NT
    J Neonatal Perinatal Med; 2022; 15(4):731-744. PubMed ID: 35811545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucrosomial
    Gómez-Ramírez S; Brilli E; Tarantino G; Girelli D; Muñoz M
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single-arm, open-label, phase 3 study in Japan.
    Sugimura M; Ohtani Y; Tamai S; Kishimoto U; Ito N
    J Obstet Gynaecol Res; 2023 Mar; 49(3):946-955. PubMed ID: 36653310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous versus Oral Iron for Iron-Deficiency Anemia in Pregnancy (IVIDA): A Randomized Controlled Trial.
    Lewkowitz AK; Stout MJ; Cooke E; Deoni SC; D'Sa V; Rouse DJ; Carter EB; Tuuli MG
    Am J Perinatol; 2022 Jun; 39(8):808-815. PubMed ID: 34839481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study.
    Ciudin A; Simó-Servat O; Balibrea JM; Vilallonga R; Hernandez C; Simó R; Mesa J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):17-20. PubMed ID: 29233512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.